Profile data is unavailable for this security.
About the company
Sansure Biotech Inc is a China-based company mainly engaged in providing overall diagnostic solutions. The Company offers an integrated and comprehensive solution covering the entire industrial chain, including reagents, instruments, sequencing services, third-party medical testing services, and the co-construction of molecular laboratories. The Company researches and develops products such as infectious disease prevention and control, maternal and child health, blood safety, cancer prevention and control, and companion diagnostics. The Company operates its business in both domestic and foreign markets.
- Revenue in CNY (TTM)1.67bn
- Net income in CNY271.49m
- Incorporated2008
- Employees2.35k
- LocationSansure Biotech IncNo.680 Lusong RoadHigh-Tech Industrial Development ZoneCHANGSHA 410205ChinaCHN
- Phone+86 73 188883176
- Fax+86 73 184223503
- Websitehttps://www.sansure.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Haohai Biological Tech Co Ltd | 2.52bn | 384.21m | 10.01bn | 2.16k | 28.54 | 1.92 | -- | 3.97 | 1.65 | 1.65 | 10.83 | 24.49 | 0.3512 | 1.53 | 7.84 | 1,169,728.00 | 4.94 | 4.58 | 5.96 | 5.26 | 69.13 | 70.39 | 14.07 | 14.67 | 3.24 | -- | 0.0656 | 42.37 | 1.64 | 10.95 | 1.04 | 2.55 | -1.86 | 14.87 |
| Shanghai Runda Medical Technology Co Ltd | 7.40bn | -157.84m | 10.04bn | 3.14k | -- | 2.40 | -- | 1.36 | -0.2609 | -0.2609 | 12.46 | 6.92 | 0.5237 | 3.68 | 1.46 | 2,360,202.00 | -0.5577 | 3.81 | -1.49 | 10.19 | 21.98 | 26.78 | -1.06 | 5.44 | 0.9723 | 1.16 | 0.5605 | 15.85 | -9.13 | 3.34 | -79.77 | -29.14 | -4.52 | -- |
| Qingdao Haier Biomedical Co Ltd | 2.26bn | 255.88m | 10.39bn | 2.81k | 40.30 | 2.41 | -- | 4.59 | 0.8144 | 0.8144 | 7.21 | 13.64 | 0.4008 | 4.31 | 5.12 | 806,199.10 | 4.68 | 10.87 | 5.92 | 14.12 | 45.31 | 49.21 | 11.67 | 24.08 | 2.41 | -- | 0.0205 | 28.14 | 0.1288 | 17.67 | -9.71 | 15.03 | -5.53 | 21.16 |
| Xiangyu Medical Co Ltd | 773.93m | 73.51m | 10.88bn | 2.34k | 142.00 | 5.37 | -- | 14.06 | 0.4789 | 0.4789 | 5.07 | 12.67 | 0.2548 | 1.01 | 11.40 | 330,597.70 | 2.35 | 8.54 | 3.26 | 10.17 | 65.98 | 66.78 | 9.22 | 28.37 | 0.9871 | -- | 0.2387 | 32.49 | -0.1717 | 11.71 | -54.68 | -4.41 | 83.55 | -- |
| Shanghai Microport EP MedTech Co Ltd | 458.70m | 52.26m | 11.21bn | 500.00 | 214.59 | 6.26 | -- | 24.45 | 0.111 | 0.111 | 0.9747 | 3.81 | 0.2395 | 1.33 | 6.85 | 917,403.00 | 2.73 | 0.9084 | 2.91 | 0.9579 | 58.24 | 64.95 | 11.39 | 4.09 | 10.17 | -- | 0.0032 | 0.00 | 25.51 | 28.61 | 815.36 | -- | 35.67 | -- |
| Beijing Wandong Medical Technolgy Co Ltd | 1.62bn | 14.41m | 11.31bn | 1.19k | 965.79 | 2.42 | -- | 6.98 | 0.0167 | 0.0167 | 2.26 | 6.66 | 0.2937 | 2.73 | 2.99 | 1,360,016.00 | 0.2623 | 4.51 | 0.304 | 5.21 | 31.59 | 42.82 | 0.8933 | 14.91 | 4.80 | -- | 0.0039 | 43.25 | 23.26 | 9.18 | -16.54 | -1.40 | -1.39 | 21.06 |
| Sansure Biotech Inc | 1.67bn | 271.49m | 11.59bn | 2.35k | 45.18 | 1.63 | -- | 6.94 | 0.4427 | 0.4427 | 2.45 | 12.31 | 0.1852 | 1.04 | 2.46 | 711,687.90 | 2.50 | 21.18 | 2.81 | 24.37 | 73.70 | 68.60 | 13.49 | 40.51 | 4.49 | -- | 0.1716 | 25.74 | 44.78 | 31.89 | -24.23 | 47.50 | 65.28 | -- |
| TINAVI Medical Technologies Co Ltd | 274.20m | -159.01m | 11.60bn | 307.00 | -- | 9.29 | -- | 42.31 | -0.3493 | -0.3493 | 0.6035 | 2.74 | 0.1673 | 2.18 | 7.63 | 893,155.40 | -10.37 | -8.02 | -11.54 | -9.16 | 70.09 | 69.64 | -62.01 | -63.51 | 2.94 | -15.75 | 0.1408 | -- | -14.85 | -4.87 | 22.54 | -- | 12.71 | -- |
| Eyebright Medical Technlgy (Bjng) Co Ltd | 1.48bn | 360.97m | 11.67bn | 2.29k | 32.05 | 4.15 | -- | 7.89 | 1.88 | 1.88 | 7.71 | 14.53 | 0.4048 | 1.89 | 3.34 | 644,799.40 | 9.90 | 10.50 | 11.54 | 12.04 | 62.91 | 75.13 | 24.45 | 31.92 | 3.28 | 24.66 | 0.1753 | 20.11 | 48.24 | 48.51 | 27.77 | 42.25 | 18.40 | -- |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.48bn | 266.86m | 11.93bn | 2.07k | 44.71 | 2.93 | -- | 8.09 | 0.6672 | 0.6672 | 3.70 | 10.18 | 0.2919 | 0.7798 | 5.17 | 714,278.40 | 5.36 | 9.00 | 6.58 | 11.05 | 64.22 | 74.07 | 18.37 | 24.98 | 4.28 | -- | 0.0011 | 22.90 | 13.18 | -1.59 | 99.22 | -12.72 | -3.40 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.47bn | 74.75m | 12.09bn | 2.01k | 156.85 | 3.26 | -- | 8.21 | 0.1647 | 0.1647 | 3.29 | 7.93 | 0.2778 | 1.92 | 2.35 | 730,874.40 | 1.07 | 1.24 | 1.51 | 1.76 | 67.29 | 68.07 | 3.85 | 4.20 | 1.60 | 4.90 | 0.0219 | 0.00 | -0.2705 | 2.71 | -5.73 | 15.09 | -11.35 | -- |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.25bn | 377.82m | 12.20bn | 832.00 | 31.78 | 3.08 | -- | 9.75 | 3.12 | 3.12 | 10.27 | 32.10 | 0.2694 | 1.56 | 3.66 | 1,515,185.00 | 7.94 | 15.38 | 9.10 | 16.87 | 68.10 | 75.38 | 29.45 | 41.85 | 4.36 | -- | 0.0043 | 46.52 | 1.61 | 29.30 | 1.96 | 28.78 | 58.53 | 35.76 |
Data as of Feb 11 2026. Currency figures normalised to Sansure Biotech Inc's reporting currency: Chinese Yuan Renminbi CNY
5.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2025 | 11.59m | 1.97% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 4.06m | 0.69% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 3.46m | 0.59% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 3.46m | 0.59% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 3.08m | 0.52% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 2.42m | 0.41% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2025 | 1.65m | 0.28% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 1.54m | 0.26% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 1.51m | 0.26% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 1.32m | 0.22% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
